Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (41-50 of 922) with videos related to

Pageof 93
Sort By:
The New England Journal of Medicine|March 10, 2017
Abdominal Aortic Aneurysm Repair in England and the United StatesKosmas I Paraskevas, Dimitri P Mikhailidis
Nature Reviews. Nephrology|November 13, 2013
Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKIDimitri P Mikhailidis, Vasilios G Athyros
Journal of Diabetes and Its Complications|January 7, 2014
Uric acid, chronic kidney disease and type 2 diabetes: a cluster of vascular risk factorsVasilios G Athyros, Dimitri P Mikhailidis
Nature Reviews. Cardiology|December 25, 2013
Dyslipidaemia in 2013: New statin guidelines and promising novel therapeuticsDimitri P Mikhailidis, Vasilios G Athyros
Journal of Diabetes and Its Complications|August 16, 2015
High incidence of metabolic syndrome further increases cardiovascular risk in patients with type 2 diabetes. Implications for everyday practiceVasilios G Athyros, Dimitri P Mikhailidis
Angiology|September 21, 2016
Contrast-Induced Acute Kidney Injury in Patients Undergoing Carotid Artery Stenting: An Underestimated IssueKosmas I Paraskevas, Dimitri P Mikhailidis
Archives of Internal Medicine|December 15, 2010
Trials by independent expert bodiesLars H Breimer, Dimitri P Mikhailidis
Interactive Cardiovascular and Thoracic Surgery|August 20, 2010
Statins may not prevent structural valve degeneration of aortic bioprosthetic valves, but should probably be prescribed to patients undergoing heart valve surgery nonethelessKosmas I Paraskevas, Dimitri P Mikhailidis
Diabetes Care|October 27, 2006
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN): response to KnoppIrene F Gazi, Dimitri P Mikhailidis
Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2006
Heparin therapy leads to platelet activation and prolongation of platelet function analyser-100 closure timeI Anita Jagroop, Dimitri P Mikhailidis
Pageof 93

Showing results (41-50 of 922) with videos related to

Sort By:
Pageof 93
The New England Journal of Medicine|March 10, 2017
Abdominal Aortic Aneurysm Repair in England and the United StatesKosmas I Paraskevas, Dimitri P Mikhailidis
Nature Reviews. Nephrology|November 13, 2013
Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKIDimitri P Mikhailidis, Vasilios G Athyros
Journal of Diabetes and Its Complications|January 7, 2014
Uric acid, chronic kidney disease and type 2 diabetes: a cluster of vascular risk factorsVasilios G Athyros, Dimitri P Mikhailidis
Nature Reviews. Cardiology|December 25, 2013
Dyslipidaemia in 2013: New statin guidelines and promising novel therapeuticsDimitri P Mikhailidis, Vasilios G Athyros
Journal of Diabetes and Its Complications|August 16, 2015
High incidence of metabolic syndrome further increases cardiovascular risk in patients with type 2 diabetes. Implications for everyday practiceVasilios G Athyros, Dimitri P Mikhailidis
Angiology|September 21, 2016
Contrast-Induced Acute Kidney Injury in Patients Undergoing Carotid Artery Stenting: An Underestimated IssueKosmas I Paraskevas, Dimitri P Mikhailidis
Archives of Internal Medicine|December 15, 2010
Trials by independent expert bodiesLars H Breimer, Dimitri P Mikhailidis
Interactive Cardiovascular and Thoracic Surgery|August 20, 2010
Statins may not prevent structural valve degeneration of aortic bioprosthetic valves, but should probably be prescribed to patients undergoing heart valve surgery nonethelessKosmas I Paraskevas, Dimitri P Mikhailidis
Diabetes Care|October 27, 2006
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN): response to KnoppIrene F Gazi, Dimitri P Mikhailidis
Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2006
Heparin therapy leads to platelet activation and prolongation of platelet function analyser-100 closure timeI Anita Jagroop, Dimitri P Mikhailidis
Pageof 93